• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

斑秃严重程度的界定:当前观点与多维框架

Defining Severity in Alopecia Areata: Current Perspectives and a Multidimensional Framework.

作者信息

King Brett A, Senna Maryanne M, Ohyama Manabu, Tosti Antonella, Sinclair Rodney D, Ball Susan, Ko Justin M, Glashofer Marc, Pirmez Rodrigo, Shapiro Jerry

机构信息

Department of Dermatology, Yale School of Medicine, PO Box 208059, New Haven, CT, 06520, USA.

Department of Dermatology, Massachusetts General Hospital and Harvard Medical School, Boston, MA, USA.

出版信息

Dermatol Ther (Heidelb). 2022 Apr;12(4):825-834. doi: 10.1007/s13555-022-00711-3. Epub 2022 Mar 31.

DOI:10.1007/s13555-022-00711-3
PMID:35357658
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC9021348/
Abstract

Alopecia areata (AA) is an autoimmune disease characterized by nonscarring hair loss. As a clinically heterogeneous disease, various classification systems have evolved for defining its severity. In this high-level review of the literature, we discuss the traditional classification systems for AA severity and their strengths and weaknesses. Most recent classifications have focused on the extent of scalp hair loss as a defining feature, but additional clinical aspects of the disease, including location, pattern, and duration of hair loss as well as impact on the patient's quality of life, are also relevant. These various components have typically been used unidimensionally to classify patients. We propose a multidimensional framework to define AA severity that incorporates multiple patient- and illness-related domains. Using such a framework, dermatologists may better assess the severity of the disease for the individual patient beyond the extent of hair loss.

摘要

斑秃(AA)是一种以非瘢痕性脱发为特征的自身免疫性疾病。作为一种临床异质性疾病,已经形成了各种分类系统来定义其严重程度。在本次对文献的高级综述中,我们讨论了斑秃严重程度的传统分类系统及其优缺点。最近的分类主要集中在头皮脱发的范围作为一个决定性特征,但该疾病的其他临床方面,包括脱发的部位、模式和持续时间以及对患者生活质量的影响,也具有相关性。这些不同的组成部分通常被单维度地用于对患者进行分类。我们提出了一个多维框架来定义斑秃的严重程度,该框架纳入了多个与患者和疾病相关的领域。使用这样一个框架,皮肤科医生可以超越脱发范围,更好地评估个体患者的疾病严重程度。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/f4cc/9021348/c055b7b7fea0/13555_2022_711_Fig1_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/f4cc/9021348/c055b7b7fea0/13555_2022_711_Fig1_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/f4cc/9021348/c055b7b7fea0/13555_2022_711_Fig1_HTML.jpg

相似文献

1
Defining Severity in Alopecia Areata: Current Perspectives and a Multidimensional Framework.斑秃严重程度的界定:当前观点与多维框架
Dermatol Ther (Heidelb). 2022 Apr;12(4):825-834. doi: 10.1007/s13555-022-00711-3. Epub 2022 Mar 31.
2
The Alopecia Areata Investigator Global Assessment scale: a measure for evaluating clinically meaningful success in clinical trials.斑秃研究者全球评估量表:一种用于评估临床试验中具有临床意义的成功的测量方法。
Br J Dermatol. 2020 Oct;183(4):702-709. doi: 10.1111/bjd.18883. Epub 2020 Apr 3.
3
Alopecia Totalis全秃
4
Alopecia areata: autoimmune basis of hair loss.斑秃:脱发的自身免疫基础。
Eur J Dermatol. 2004 Nov-Dec;14(6):364-70.
5
Dermatologist and Patient Perceptions of Treatment Success in Alopecia Areata and Evaluation of Clinical Outcome Assessments in Japan.日本皮肤科医生和患者对斑秃治疗成功率的看法及临床疗效评估
Dermatol Ther (Heidelb). 2021 Apr;11(2):433-447. doi: 10.1007/s13555-020-00477-6. Epub 2021 Jan 10.
6
Childhood Alopecia Areata: An Overview of Treatment and Recent Patents.儿童斑秃:治疗概述及近期专利。
Recent Pat Inflamm Allergy Drug Discov. 2020;14(2):117-132. doi: 10.2174/1872213X14999200728145822.
7
Alopecia Areata: Review of Epidemiology, Clinical Features, Pathogenesis, and New Treatment Options.斑秃:流行病学、临床特征、发病机制及新治疗选择综述
Int J Trichology. 2018 Mar-Apr;10(2):51-60. doi: 10.4103/ijt.ijt_99_17.
8
The Alopecia Areata Severity and Morbidity Index (ASAMI) Study: Results From a Global Expert Consensus Exercise on Determinants of Alopecia Areata Severity.斑秃严重度和发病率指数(ASAMI)研究:全球专家共识关于斑秃严重度决定因素的结果。
JAMA Dermatol. 2024 Mar 1;160(3):341-350. doi: 10.1001/jamadermatol.2023.5869.
9
Alopecia areata: Disease characteristics, clinical evaluation, and new perspectives on pathogenesis.斑秃:疾病特征、临床评估及发病机制的新观点。
J Am Acad Dermatol. 2018 Jan;78(1):1-12. doi: 10.1016/j.jaad.2017.04.1141.
10
Patient-Reported Burden of Severe Alopecia Areata: First Results from the Multinational Alopecia Areata Unmet Need Survey.患者报告的重度斑秃负担:多国斑秃未满足需求调查的初步结果
Clin Cosmet Investig Dermatol. 2024 Mar 29;17:751-761. doi: 10.2147/CCID.S445646. eCollection 2024.

引用本文的文献

1
Clinical Assessment of Alopecia Areata Severity and Validating the Patient Experience: A Vodcast.斑秃严重程度的临床评估及患者体验验证:网络视频广播
Am J Clin Dermatol. 2025 Aug 14. doi: 10.1007/s40257-025-00973-5.
2
Patient-Reported Psychosocial Burdens and Quality of Life and Work Productivity Impacts Among Patients with Clinically Distinct Alopecia Areata Severity Profiles.不同临床严重程度斑秃患者的患者报告心理社会负担、生活质量及工作效率影响
Adv Ther. 2025 Jul 21. doi: 10.1007/s12325-025-03302-8.
3
Alopecia Areata: Impact on Patients' Quality of Life and Disease Perception: A Survey-Based Study.

本文引用的文献

1
Development of the alopecia areata scale for clinical use: Results of an academic-industry collaborative effort.用于临床的斑秃量表的开发:一项学术-产业合作成果
J Am Acad Dermatol. 2022 Feb;86(2):359-364. doi: 10.1016/j.jaad.2021.08.043. Epub 2021 Aug 30.
2
Recommended core outcome instruments for health-related quality of life, long-term control and itch intensity in atopic eczema trials: results of the HOME VII consensus meeting.特应性皮炎临床试验中与健康相关的生活质量、长期控制和瘙痒强度的推荐核心结局指标:HOME VII 共识会议的结果。
Br J Dermatol. 2021 Jul;185(1):139-146. doi: 10.1111/bjd.19751. Epub 2021 Feb 8.
3
斑秃:对患者生活质量和疾病认知的影响:一项基于调查的研究
Acta Derm Venereol. 2025 Jul 19;105:adv43318. doi: 10.2340/actadv.v105.43318.
4
The Diverse Experiences and Challenges of Individuals With Alopecia Areata: Survey Results From Finland.斑秃患者的多样经历与挑战:芬兰的调查结果
J Patient Exp. 2025 Jun 3;12:23743735251346633. doi: 10.1177/23743735251346633. eCollection 2025.
5
Assessment of Intestinal Free Fatty Acid Binding Protein 4 in Alopecia Areata Patients.斑秃患者肠道游离脂肪酸结合蛋白4的评估
Skin Appendage Disord. 2025 Apr;11(2):112-118. doi: 10.1159/000541111. Epub 2024 Oct 3.
6
Safety and Efficacy of Ritlecitinib for the Treatment of Patients with Alopecia Areata: A Systematic Review and Meta-Analysis of Controlled Trials.利特昔替尼治疗斑秃患者的安全性和有效性:一项对照试验的系统评价和荟萃分析
J Clin Med. 2025 Mar 8;14(6):1817. doi: 10.3390/jcm14061817.
7
Evaluation of SALT score severity in correlation with trichoscopic findings in alopecia areata: a study of 303 patients.斑秃中SALT评分严重程度与毛发镜检查结果的相关性评估:一项对303例患者的研究
Arch Dermatol Res. 2025 Mar 7;317(1):523. doi: 10.1007/s00403-025-04026-z.
8
Assessment of Alopecia Areata Disease Severity in Pediatric Patients.儿童斑秃疾病严重程度评估
Pediatr Dermatol. 2025 Mar;42 Suppl 1(Suppl 1):31-35. doi: 10.1111/pde.15830.
9
Patterns of clinical response in patients with alopecia areata treated with ritlecitinib in the ALLEGRO clinical development programme.在ALLEGRO临床开发项目中,接受利特昔替尼治疗的斑秃患者的临床反应模式。
J Eur Acad Dermatol Venereol. 2025 Jun;39(6):1163-1173. doi: 10.1111/jdv.20547. Epub 2025 Feb 17.
10
Long-term safety and efficacy of ritlecitinib in adults and adolescents with alopecia areata and at least 25% scalp hair loss: Results from the ALLEGRO-LT phase 3, open-label study.利特昔替尼治疗斑秃且至少25%头皮脱发的成人和青少年的长期安全性和有效性:ALLEGRO-LT 3期开放标签研究结果
J Eur Acad Dermatol Venereol. 2025 Jan 23. doi: 10.1111/jdv.20526.
Eyebrows Are Important in the Treatment of Alopecia Areata.
眉毛在斑秃治疗中很重要。
J Investig Dermatol Symp Proc. 2020 Nov;20(1):S37-S40. doi: 10.1016/j.jisp.2020.04.006.
4
The Alopecia Areata Consensus of Experts (ACE) study part II: Results of an international expert opinion on diagnosis and laboratory evaluation for alopecia areata.斑秃专家共识(ACE)研究第二部分:关于斑秃诊断和实验室评估的国际专家意见结果
J Am Acad Dermatol. 2021 Jun;84(6):1594-1601. doi: 10.1016/j.jaad.2020.09.028. Epub 2020 Sep 12.
5
"'You lose your hair, what's the big deal?' I was so embarrassed, I was so self-conscious, I was so depressed:" a qualitative interview study to understand the psychosocial burden of alopecia areata.“你掉头发而已,有什么大不了的?”我当时非常尴尬,极度在意自己的形象,十分沮丧:一项关于了解斑秃心理社会负担的定性访谈研究
J Patient Rep Outcomes. 2020 Sep 11;4(1):76. doi: 10.1186/s41687-020-00240-7.
6
The Alopecia Areata Consensus of Experts (ACE) study: Results of an international expert opinion on treatments for alopecia areata.斑秃专家共识(ACE)研究:斑秃治疗国际专家意见的结果。
J Am Acad Dermatol. 2020 Jul;83(1):123-130. doi: 10.1016/j.jaad.2020.03.004. Epub 2020 Mar 9.
7
The Alopecia Areata Investigator Global Assessment scale: a measure for evaluating clinically meaningful success in clinical trials.斑秃研究者全球评估量表:一种用于评估临床试验中具有临床意义的成功的测量方法。
Br J Dermatol. 2020 Oct;183(4):702-709. doi: 10.1111/bjd.18883. Epub 2020 Apr 3.
8
Measurement Properties of the Hospital Anxiety and Depression Scale Used in Atopic Dermatitis in Adults.成人特应性皮炎中使用的医院焦虑抑郁量表的测量属性
J Invest Dermatol. 2019 Jun;139(6):1388-1391. doi: 10.1016/j.jid.2018.11.029. Epub 2018 Dec 17.
9
Treatment of alopecia areata: An Australian expert consensus statement.斑秃治疗:澳大利亚专家共识声明。
Australas J Dermatol. 2019 May;60(2):163-170. doi: 10.1111/ajd.12941. Epub 2018 Nov 8.
10
Rethinking the classification of alopecia areata.斑秃分类的再思考。
J Am Acad Dermatol. 2019 Feb;80(2):e45. doi: 10.1016/j.jaad.2018.08.059. Epub 2018 Sep 20.